ESTRO/LinkedIn
Nov 1, 2024, 19:12
ESTRO: Toxicity Profile of Immune Therapy Combined with Radiotherapy
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Are there potential increased risks of toxicities when immunotherapy and radiotherapy are combined? Current data presented at ESTROAsia24 suggest no, but sequencing and tissue microenvironment may play a role.
The impact of complex combinations of different immuno agents and RT remains unknown.”
More posts featuring ESTRO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 16:56
Mar 30, 2025, 16:44
Mar 30, 2025, 16:43
Mar 30, 2025, 16:03
Mar 30, 2025, 15:52
Mar 30, 2025, 15:48
Mar 30, 2025, 15:37